2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid

C24H42N6O11 — CID 176706959

IUPAC2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid
SMILESO=CCN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1
InChIInChI=1S/C24H42N6O11/c31-14-13-25-1-3-26(15-20(32)33)5-7-28(17-22(36)37)9-11-30(19-24(40)41)12-10-29(18-23(38)39)8-6-27(4-2-25)16-21(34)35/h14H,1-13,15-19H2,(H,32,33)(H,34,35)(H,36,37)(H,38,39)(H,40,41)
InChIKeyKCJKRROUQMQNNO-UHFFFAOYSA-N
MW590.63 g/mol
LogP-3.57
Rot. Bonds12

About 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid

2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid (PubChem CID 176706959) has the molecular formula C24H42N6O11 and a molecular weight of 590.63 g/mol. Its IUPAC name is 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid.

Molecular Properties

Compound Name2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid
PubChem CID176706959
Molecular FormulaC24H42N6O11
Molecular Weight590.63 g/mol
Exact Mass590.29
IUPAC Name2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid
SMILESO=CCN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1
InChIInChI=1S/C24H42N6O11/c31-14-13-25-1-3-26(15-20(32)33)5-7-28(17-22(36)37)9-11-30(19-24(40)41)12-10-29(18-23(38)39)8-6-27(4-2-25)16-21(34)35/h14H,1-13,15-19H2,(H,32,33)(H,34,35)(H,36,37)(H,38,39)(H,40,41)
InChIKeyKCJKRROUQMQNNO-UHFFFAOYSA-N
XLogP-3.57
TPSA223.01 Ų
H-Bond Donors5
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500590.63
LogP ≤ 5-3.57
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid?
The IUPAC name of 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid (CID 176706959) is 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid.
What is the SMILES notation for 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid?
The canonical SMILES for 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid is O=CCN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1.
What is the InChIKey of 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid?
The InChIKey is KCJKRROUQMQNNO-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H42N6O11/c31-14-13-25-1-3-26(15-20(32)33)5-7-28(17-22(36)37)9-11-30(19-24(40)41)12-10-29(18-23(38)39)8-6-27(4-2-25)16-21(34)35/h14H,1-13,15-19H2,(H,32,33)(H,34,35)(H,36,37)(H,38,39)(H,40,41).
What are the key properties of 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid?
2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid has a molecular weight of 590.63 g/mol, XLogP of -3.57, 12 rotatable bonds, 5 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4,7,10,13-tetrakis(carboxymethyl)-16-(2-oxoethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]acetic acid is sourced from PubChem (CID 176706959), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).